Drug Interaction Oral Contraceptive Pill (OCP)

Completed · Phase 1

Conditions studied: Hepatitis C Virus

In brief

To assess the effects of BMS-650032 on Pharmacokinetics (PK) of ethinyl estradiol (EE) and norelgestromin (NGMN) in healthy female subjects

Key facts

Study ID

NCT01063023

Run by

Bristol-Myers Squibb

People needed

20

Starts

2010-01-01

Expected to finish

2010-06-01

Last updated by the study team

2011-01-25

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy Females, 18-40 years, BMI 18 - 32kg/m². Must use an acceptable method of contraception to avoid pregnancy throughout the study and 8 weeks after last dose of study drug

You may not qualify if…

• Abnormal pap smear within 1 year prior to day 1
• Any significant or chronic uncontrolled medical illness

Where it is running

• Pra International — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.